Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Schoenfeld

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Drugs|June 3, 2017
Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid TumorsDavid A Schoenfeld
Critical Care (London, England)|February 8, 2005
Pro/con clinical debate: It is acceptable to stop large multicentre randomized controlled trials at interim analysis for futility. Pro: Futility stopping can speed up the development of effective treatmentsDavid A Schoenfeld
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|February 15, 2008
Design of phase II ALS clinical trialsDavid A Schoenfeld, Merit Cudkowicz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Correcting for discretionary treatment crossover in an analysis of survival in the Breast International Group BIG 1-98 trial by using the inverse probability of censoring weighted methodDianne M Finkelstein, David A Schoenfeld
Circulation|January 4, 2007
Survival methodsSowmya R Rao, David A Schoenfeld
Statistics in Medicine|September 13, 2018
Graphing the Win Ratio and its components over timeDianne M Finkelstein, David A Schoenfeld
Statistics in Medicine|February 7, 2014
A joint test for progression and survival with interval-censored data from a cancer clinical trialDianne M Finkelstein, David A Schoenfeld
Critical Care Medicine|August 7, 2002
Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndromeDavid A Schoenfeld, Gordon R Bernard,
Clinical Trials (London, England)|February 25, 2016
Assessing survival benefit when treatment delays disease progressionDavid A Schoenfeld, Dianne M Finkelstein
Statistics in Medicine|August 2, 2011
Optimality, sample size, and power calculations for the sequential parallel comparison designAnastasia Ivanova, Bahjat Qaqish, David A Schoenfeld
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Drugs|June 3, 2017
Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid TumorsDavid A Schoenfeld
Critical Care (London, England)|February 8, 2005
Pro/con clinical debate: It is acceptable to stop large multicentre randomized controlled trials at interim analysis for futility. Pro: Futility stopping can speed up the development of effective treatmentsDavid A Schoenfeld
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|February 15, 2008
Design of phase II ALS clinical trialsDavid A Schoenfeld, Merit Cudkowicz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Correcting for discretionary treatment crossover in an analysis of survival in the Breast International Group BIG 1-98 trial by using the inverse probability of censoring weighted methodDianne M Finkelstein, David A Schoenfeld
Circulation|January 4, 2007
Survival methodsSowmya R Rao, David A Schoenfeld
Statistics in Medicine|September 13, 2018
Graphing the Win Ratio and its components over timeDianne M Finkelstein, David A Schoenfeld
Statistics in Medicine|February 7, 2014
A joint test for progression and survival with interval-censored data from a cancer clinical trialDianne M Finkelstein, David A Schoenfeld
Critical Care Medicine|August 7, 2002
Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndromeDavid A Schoenfeld, Gordon R Bernard,
Clinical Trials (London, England)|February 25, 2016
Assessing survival benefit when treatment delays disease progressionDavid A Schoenfeld, Dianne M Finkelstein
Statistics in Medicine|August 2, 2011
Optimality, sample size, and power calculations for the sequential parallel comparison designAnastasia Ivanova, Bahjat Qaqish, David A Schoenfeld
Pageof 12